Actigraphy (ACT) can enhance treatment for insomnia by providing objective estimates of sleep efficiency; however, only two studies have assessed the accuracy of actigraphy-based estimates of sleep efficiency (ACT-SE) in sleep-disordered samples studied at home. Both found poor correspondence with polysomnography-based estimates (PSG-SE). The current study tested that concordance in a third sample and piloted a method for improving ACT-SE. Participants in one of four diagnostic categories (panic disorder, post-traumatic stress disorder, comorbid post-traumatic stress and panic disorder and controls without sleep complaints) underwent in-home recording of sleep using concurrent ambulatory PSG and actigraphy. Precisely synchronized PSG and ACT recordings were obtained from 41 participants. Sleep efficiency was scored independently using conventional methods, and ACT-SE/PSG-SE concordance examined. Next, ACT data recorded initially at 0.5 Hz were resampled to 30-s epochs and rescaled on a perparticipant basis to yield optimized concordance between PSG-and ACTbased sleep efficiency estimates. Using standard scoring of ACT, the correlation between ACT-SE and PSG-SE across participants was statistically significant (r = 0.35, P < 0.025), although ACT-SE failed to replicate a main effect of diagnosis. Individualized calibration of ACT against a night of PSG yielded a significantly higher correlation between ACT-SE and PSG-SE (r = 0.65, P < 0.001; z = 1.692, P = 0.0452, one-tailed) and a significant main effect of diagnosis that was highly correspondent with the effect on PSG-SE. ACT-based estimates of sleep efficiency in sleep-disordered patients tested at home can be improved significantly by calibration against a single night of concurrent PSG.
IN TROD UCTI ON
Polysomnography (PSG) is the gold standard for measuring sleep objectively; however, its complexity, expense and burden limit its use outside medical sleep disorders. In contrast, actigraphy (ACT) employs a simple wrist-or legworn accelerometer combined with digitization and memory storage. One of three methods 1 is used to convert the accelerometer output voltage to a movement event or count, and a smoothing filter is applied to the movement data to implement the expectation that sleep and wake do not alternate on a minute-to-minute basis. ACT has well-understood limitations, most notably error in distinguishing sleep from wake during periods of low movement (Paquet et al., 2007) . Published studies using actigraphy to measure sleep have increased exponentially since 1994 (see Supporting information, Fig. S1 ). The American Association of Sleep Medicine (Littner et al., 2003; Morgenthaler et al., 2007) has held that actigraphy is reliable and valid for detecting sleep in normal populations, and indicated for evaluating circadian rhythm disorders; nevertheless, only a minority of these studies are focused on circadian rhythm disorders, with many addressing insomnia and other sleep disorders. An attractive potential use of ACT is the quantification of sleep efficiency (SE) during a course of insomnia treatment. Most versions of cognitive-behavioural therapy for insomnia 1 The transduction and thresholding of movement is accomplished by three common algorithms (Jean-Louis, 2001 ). The zero-crossing mode (ZCM) quantifies movement by comparing the signal voltage from the accelerometer with a reference voltage and generating an activity count based on the number of times the accelerometer waveform crosses zero per sample period. The time-above-threshold mode (TAT) measures the length of time the accelerometer waveform is above a reference voltage. The proportional integral mode (PIM) quantifies the area under the rectified analogue signal curve, generating an accumulated count for each sample period.
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1 of 7 J Sleep Res. (2018) 27, 1-7 Methodology (CBT-I), a leading treatment for this diagnosis, target increasing SE specifically through restriction of time in bed. SE is an integrative sleep measure that incorporates the variation seen in other sleep variables such as sleep onset latency, wake after sleep onset and total sleep time.
How well does ACT measure sleep efficiency? A number of studies have addressed this question (Van De Water et al., 2011) , and they can be stratified according to their relevance to evaluation of insomnia in the home setting: (1) laboratory studies in healthy volunteers, (2) laboratory studies in sleepdisordered samples, (3) home studies in healthy volunteers and (4) home studies in sleep-disordered samples.
Studies in the first category, which is also the largest, generally report the highest concordance 2 between ACTbased SE and PSG-based SE, with correlation coefficients ranging from 0.31 to 0.91 (De Souza et al., 2003; Jean-Louis et al., 2001a,b; Laakso et al., 2004; Marino et al., 2013; Paquet et al., 2007) . When sleep-disordered patients are recorded concurrently in the laboratory, ACT-SE/PSG-SE concordances are generally lower, with reported correlations in the range of 0.43-0.48 (Lichstein et al., 2006; Mccall and McCall, 2012) . In samples with frankly impaired mobility even laboratory-based concordances between ACT-SE and PSG-SE can be extremely low, with correlation coefficients as low as 0.04 (Ancoli-Israel et al., 1997; Beecroft et al., 2008; Laakso et al., 2004) . Representing the third category, Blackwell and colleagues conducted two large home-based studies with community-dwelling women and men at risk for osteoporotic fractures and found intraclass correlation coefficients (ICCs) between ACT-SE and PSG-SE ranging from 0.16 to 0.61 (Blackwell et al., 2008 (Blackwell et al., , 2011 . In a non-sleepdisordered subsample studied in the home, Sanchez-Ortuno observed a non-significant ACT-SE/PSG-SE correlation of 0.23 (Sanchez-Ortuno et al., 2010) . Only two studies have compared ACT-SE with PSG-SE in adults with sleep complaints studied in the home. In an insomniac subsample screened for primary sleep disorders, Sanchez-Ortuno observed a correlation of 0.41 between ACT-SE and PSG-SE (Sanchez-Ortuno et al., 2010) , suggesting that ACT-SE explained only approximately 16% of the variance in goldstandard PSG-SE. Moreover, while PSG-SE exhibited a main effect of insomnia group, ACT-SE did not. Baandrup and Jennum compared ACT-SE and PSG-SE in schizophrenic and bipolar disorder patients studied at home and found the correlation between ACT-SE and PSG-SE to be 'at or close to zero' (Baandrup and Jennum, 2015, p. 2273) . In sum, while the literature as a whole can be viewed as supporting reasonable correspondence between ACT-SE and PSG-SE, support for this proposition erodes the closer we approach its potential utility for evaluating insomnia in the home.
This paper reports on a third examination of ACT-PSG concordance in the home in a new clinical sample representative of people who might benefit from behavioural sleep interventions: anxiety-disordered patients with sleep complaints. The sample, as described in detail in Woodward et al. (2009) , included subgroups with panic disorder (PD), posttraumatic stress disorder (PTSD) and comorbid PD and PTSD. The sample also included a control group with no mental illness and no sleep complaints. In the analyses reported below, we focus solely on SE. We estimate concordance between ACT-SE and PSG-SE utilizing standard scoring of the former using the manufacturer's software. We then describe in detail a simple method to calibrate ACT so that ACT-SE approximates PSG-SE more closely.
METH ODS Participants
This research was performed under the aegis of the Stanford/ VA Palo Alto Human Research Protection Program. Participants were recruited from the community using radio and newspaper advertisements emphasizing disturbances of sleep due to distressing experiences, fear and anxiety and/ or nightmares and nocturnal panic attacks. The recruitment of participants denying subjective sleep complaints relied principally on personal contacts between study participants and staff and their social networks. Telephone screening excluded callers if they reported current medical illness, histories of central nervous system disease or injury, a Multivariate Apnea Prediction Index (MAPI; Maislin et al., 1995) greater than 0.5 or a previously diagnosed sleep apnea or periodic limb movement disorder. People were also excluded if they were currently abusing alcohol or other psychotrophic substances, or were unwilling to discontinue hypnotic medications. Provisional diagnoses were made through telephone screening, which took 15-60 min per participant. Participants passing screening travelled to the research setting, provided written informed consent and underwent structured psychiatric interviews. Diagnoses of PTSD and PD were based upon the clinician-administered PSTD Scale (CAPS; Blake et al., 1997) and the PD section of the Structured Clinical Interview for the DSM-IV (SCID; Spitzer et al., 1996) , respectively. Index traumas were mainly incidents such as motor vehicle accidents, criminal victimizations and exposures related to the 1989 Loma Prieta earthquake. Screening of other Axis I psychopathology was confirmed using the Mini-International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998) . Seventeen participants meeting screening and diagnostic criteria declined to return for a screening PSG. Ten participants exceeded the apneahypopnea index (AHI) criterion of > 10 events h À1 and three exceeded the periodic limb movement arousal index criterion of > 20 events h
À1
. Ten participants who passed the screening PSG declined to undergo in-home recording. Sixty-six participants were recorded successfully in the home using Concordance is reported by correlation coefficients, which include Pearson's product-moment correlation coefficient, Spearman's rank order correlation coefficient or intraclass correlation coefficient, depending on the statistics reported in the study.
ª Published 2017. This article is a U.S. Government work and is in the public domain in the USA. concurrent PSG and mattress ACT (cf. Woodward et al., 2007) . Temporal co-registration of PSG, mattress ACT and ankle ACT was achieved with better than AE 1.2-s precision (see below) in 41 participants who constituted the final sample for this analysis. They were distributed throughout diagnostic categories as follows: controls (CONT): 13; panic disorder (PD): 7; post-traumatic stress disorder (PTSD): 14; and comorbid PTSD+PD: 7. Participants maintained their non-hypnotic medications. Rates of psychotrophic medication use differed over diagnostic groups (CONT: 0%, PD; 18%; PTSD: 27%; PTSD+PD: 45%; v 2 (3) = 7.87, P < 0.05). Among participants with panic disorder and/or PTSD, there were no significant associations between diagnosis and class of medication. No participants were taking stimulants or betablockers. Three participants reported having prescriptions for hypnotic medications which they discontinued. Participants received pro-rated payments for their participation up to a maximum of $300, depending upon how many nights of home recording they underwent.
Procedures
The apnea screening PSG was performed in the laboratory. That montage included electroencephalogram (EEG, Cz and Pz referenced to linked ears), electro-oculogram (EOG, vertical and horizontal), submental electromyogram (EMG), bilateral anterior tibialis EMG and oral/nasal airflow (thermistor) and ECG and respiratory effort (RESP, inductive plethysmography, thoracic and abdominal bands). Home sleep recording took place an average of 40 days after the screening PSG. Ambulatory PSG was performed using an Oxford MR95 digital data logger (Oxford Instruments, Abingdon, UK) and included EEG (Cz and Pz referenced to linked ears), horizontal EOG, submental EMG and ECG. Laboratory and home PSG data were scored by the same technician using conventional criteria with the addition of a 'quiet wake' classification, which was applied to epochs combining clear evidence of EEG waking in the absence of any appreciable body movement (Rechtschaffen and Kales, 1968) . Sleep onset and offset times were defined as the first and last epochs of sleep as scored by PSG.
Ankle ACT 3 employed an 'Octagonal' Motionlogger actigraphy (Ambulatory Monitoring, Inc., Ardsley, NY, USA) operating in proportional integration mode (PIM) and sampling movement at 0.5 Hz. The use of PIM mode, which in this actigraph preserves relative movement amplitude at 8-bit resolution, together with a relatively fast sampling rate, were instrumental in enabling precise temporal synchronization of ACT with PSG. As the MR95 system did not access an external computer clock, concurrently recorded mattress actigraphy (Woodward et al., 2007 (Woodward et al., , 2009 ) was also crucial in achieving the necessary synchronization by supplying reference signals which could be synchronized with both PSG and ACT data. 4 To synchronize PSG and mattress ACT, R-waves in the ECG and J-waves in the mattressrecorded kinetocardiogram (native sampling rate, 600 Hz) were detected and their locations in time saved as unit vectors. These vectors were cross-correlated and time offsets calculated to a precision of approximately AE 10 ms.
To synchronize ankle and mattress ACT data, the latter were summed over sensors and down-sampled from 600 to 0.5 Hz. These two ACT vectors were then cross-correlated and offsets calculated to a precision of AE 2 s. The two offsets were summed to bring the PSG and ACT into synchronization with a precision of AE 2 s. After synchronization, the ACT data were resampled to 30-s epochs to correspond with the PSG scoring. Synchronizations were verified manually (see Supporting information). These manipulations were performed using custom software developed in Matlab (Natick, MA, USA). 5 As demonstrated in the Supporting information, Fig. S2 , post-synchronization, the raw AMI PIM-mode data replicated the expected relationships between sleep stages and movement amplitudes with progressively lower movement indices as sleep deepened from classical stages 1-4, much higher rates during waking and highest during 'artefact' periods which were typically mid-sleep bathroom breaks (Stefani et al., 2015; Wilde-Frenz and Schulz, 1983) . PSG-SE was calculated in the conventional manner as the ratio of time asleep to time in bed. ACT-SE was obtained using the standard University of California San Diego (UCSD) scoring algorithm incorporated in Action 4 software supplied by AMI (AMI Software, Cambridge, UK), applied to 60-s epochs with sleep onsets and offsets for actigraphic scoring imported from PSG.
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The rescaling and calibration of the ACT data was performed as follows. First, for each participant, the PSGbased sleep staging was simplified by assigning 1 to all sleep epochs and 2 to all wake epochs. This simplified PSG timeseries was then cross-correlated iteratively with a simplified ACT time-series achieved by multiplying the resampled ACT data by a scaling factor and thresholding to yield, again, a 1 = sleep versus 2 = wake time series. This automated search found the scaling factor which yielded the highest cross-correlation between the PSG and ACT vectors. The range of optimal scaling factors was quite large, from 0.08 to 19.23, and were not distributed normally (see Fig. 1 ). After rescaling, calibrated ACT-SE was calculated simply as 3 Ankle site was chosen to allow investigation of the detectability of periodic leg movements and in particular to compare anterior tibialis EMG with accelerometry for measuring limb myoclonus (cf. Athavale et al., 2017) . 4 The Oxford MR95 was the first digital ambulatory PSG system available in the United States. Most such systems currently provide for synchronization to an external time server such as a desktop computer, which can also be shared with an actigraphic system, obviating the use of an intermediate reference.
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All codes used in the preparation of this paper are available on request from the second author. 6 Action 4 automatically aggregates data sampled at faster rates to the standard 60-s epochs used in actigraphy.
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100 minus the percentage of 30-s epochs in which summed rescaled movement counts exceeded the arbitrary threshold value of 1; that is, without the smoothing filter described by Jean-Louis et al. (2001a) , and incorporated into most commercial software.
Data analysis
Statistical analyses were performed using IBM SPSS statistics version 21.0. Analyses included Pearson's correlation analyses between PSG-SE and ACT-SE and between PSG-SE and calibrated ACT-SE, univariate analysis of variance using a general linear model to evaluate differences in sleep efficiency by diagnostic group, Tukey's post-hoc test to examine differences in error estimates by diagnostic group and t-tests to examine change in ACT-SE/PSG-SE concordance and error estimates after calibration. Fig. 2a , Pearson's product-moment correlation between PSG-SE and uncalibrated ACT-SE was significant at r = 0.35 (P < 0.025). However, the bivariate relationship was skewed asymmetrically and included many cases in which ACT-SE overestimated PSG-SE. As shown in Fig. 3 , the effect of diagnostic group on PSG-SE was significant (F (3,40) = 4.08, P = 0.013), with the PTSD+PD group having the lowest mean PSG-SE at 78.8%. Although ACT-SE exhibited a similar profile over groups, the group effect was not significant (F (3,40) = 1.50, P = 0.231). Moreover, although the PTSD + PD group demonstrated the lowest ACT-SE throughout groups at 91.2%, it was not clearly in the clinical range. ACT-SE error was distributed normally with a mean of 7.46 [standard deviation (SD) = 8.15]. The effect of group on ACT-SE error was not significant (F (3,40) = 1.29, P = 0.29); however, the difference between the errors in the worstsleeping PTSD + PD group and the PTSD-only group approached significance (Tukey's LSD; P = 0.058), suggestive of systematic bias. ACT-SE error was correlated positively with the percentage of PSG--wake epochs devoid of movement (as detected via ACT, r = 0.33, P = 0.034).
RESULTS

As shown in
Calibrated ACT-SE was correlated with PSG-SE at r = 0.65 (P < 0.001), with a relatively symmetric bivariate distribution and a reduction in the number of cases exhibiting severe overestimation (see Fig. 2b ). The increase in the strength of the correlation with PSG-SE was significant (z = 1.69, P = 0.0452, one-tailed). As shown in Fig. 4 , calibrated ACT-SE was, on average, 2.2% lower than the value produced by Action 4 standard scoring (t (40) = 2.58, P = 0.014). The main effect of group on calibrated ACT-SE was significant (F (3,40) = 3.31, P = 0.031), due in part to smaller within group standard deviations. Calibrated ACT-SE error was distributed normally with a mean of 5.18 (SD = 6.40), which was significantly smaller than Action 4 SE error (t (40) = 2.58, P = 0.014). The effect of group on calibrated ACT-SE error was not significant (F (3,40) = 1.13, P = 0.35) and evidence of systematic bias reduced somewhat (difference between the errors in the worst-sleeping PTSD+PD group and the PTSD-only group, Tukey's LSD; P = 0.13). Calibrated ACT-SE error was no longer correlated with the percentage of PSG-wake epochs devoid of movement (r = 0.17, P = 0.284).
DISCUSSION
This study confirms previous findings, that ACT underestimates wakefulness during periods of low movement and overestimates SE, when compared with PSG-derived SE. It extends this finding to anxiety-disordered patients measured in the home. The correlation of calibrated ACT-SE and PSG-SE in this study was modestly higher than in previous home studies using clinical samples (Baandrup and Jennum, 2015; Sanchez-Ortuno et al., 2010) . Calibrated ACT-SE estimates in this study were improved meaningfully from the standard ACT-SE scoring through the application of an individualized scaling factor obtained by comparison to concurrently recorded PSG. The rescaling procedure is mathematically straightforward and relies upon features that are available from many actigraph devices, including PIM mode and sampling rates >/= 0.5 Hz. As zeromovement ACT epochs cannot be rescaled, this improvement must rely upon amplification/attenuation of non-zero epochs of ACT. Many modern actigraphs provide the temporal and amplitude resolution needed for calibration against PSG, which may then be accomplished using a spreadsheet.
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That ACT-SE estimates can be improved by rescaling probably reflects the fact that individuals differ in their habitual motility. This was suggested by the wide range of scaling factors observed in our sample. As reviewed above, in samples with frankly impaired mobility, concordances between ACT and PSG are especially low (Ancoli-Israel et al., 1997; Beecroft et al., 2008; Laakso et al., 2004 ). An individualized approach to calibration provides an advantage over simply resetting the sleep detection threshold, as it accounts for this variability in movement on a person-to-person basis. Further support for the utility of such an approach is that certain psychiatric diagnoses may be associated with less movement during sleep than comparison groups (Jean-Louis et al., 2000; Woodward et al., 2002) . Such differences, if unaccounted for, threaten the validity of ACT-based comparisons.
With an increase in the use of passive health data and data science to address population health questions (Eysenbach, 2009) , we anticipate an ongoing need for refinement in easily deployable sleep technologies such as ACT. While other attractive technologies are under development, it would be of great value to optimize the validity and reliability of the most widely used of these technologies to help improve objective measures of sleep.
One potential use of improved ACT technology is the quantification of sleep efficiency during a course of insomnia treatment. Behavioural sleep prescriptions in CBT-I, such as recommendations for bedtime, wake time and sleep restriction, are based primarily on estimates of SE derived from patients' self-reports of in-bed, out-of-bed and intracurrent wake times. It has not yet been demonstrated conclusively that actigraphy can enhance CBT-I; however, PubMed lists 27 CBT-I trials that . Actigraphy (ACT) and calibrated ACT-derived sleep efficiency estimates by diagnostic group. The effect of diagnostic group was significant for calibrated ACT-sleep efficiency (SE) (F (3,40) = 3.31, P = 0.031) but not for ACT-SE (F (3,40) = 1.50, P = 0.231).
A spreadsheet template for the calibration method is available on request from the second author.
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have employed actigraphy in some capacity, following the first to do so only 6 years ago (Garland et al., 2011) . For example, in a recent trial of CBT-I in PTSD patients, Talbot et al. (2014) used actigraphy as a participant accountability check to improve compliance with the sleep diary (Talbot et al., 2014) . If ACT provided an accurate objective measure of SE during CBT-I, it could potentially improve sleep prescriptions and enhance safety by identifying cases in which restriction did not consolidate sleep. Other potential applications include improved measurement of sleep as a form of passive health data, which are being used increasingly in population-based risk prediction and prevention studies. We anticipate that sleep, which affects wellbeing across illness domains, will be an important variable of interest for both clinical and research applications in the emerging field of electronic predictive health analytics (Amarasingham et al., 2014) . When feasible, inclusion of a single night of concurrent ACT and PSG could actually lower aggregate burden by reducing the sizes of samples needed to achieve desired levels of statistical power. This impact on power would probably be compounded by the more reliable exclusion of primary sleep disorders when they are not the focus of study. In the further development of CBT-I and newer psychotherapies for insomnia and the parasomnias, the inclusion of a valid, objective and low-burden measure of sleep efficiency, the principal in-process target of behavioural sleep interventions, would enhance monitoring of treatment response, adherence, mediators and process factors.
This study is limited by its use of a convenience sample of small size and its reliance upon a single brand of actigraph. We employed concurrent mattress actigraphy for synchronization due to the ambulatory PSG montage not having an external computer clock; to our knowledge, this has no significant implications for validity or comparability of the actigraphic data, but will not be a required intermediate step in future studies. Future directions should include replication in a larger sample and extension to lower-cost actigraphic devices and technologies now available.
SU PPORTI NG I NFOR MA TION
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . Number of studies catalogued in the PubMed search engine that carry 'actigraphy' or 'actigraphy + sleep efficiency' tags, by year of publication. Figure S2 . Mean proportional integration mode (PIM) counts by sleep stage. This chart demonstrates the expected relationships between sleep stages and movement amplitudes measured by actigraphy, with progressively lower movement indices as sleep deepened from classical stages 1 to 4, much higher rates during waking and highest during 'artefact' periods, which were typically mid-sleep bathroom breaks. Figure S3 . Example of actigraphy-polysomnography synchronization and calibration (subject 1). Figure S4 . Example of actigraphy-polysomnography synchronization and calibration (subject 11). Figure S5 . Example of actigraphy-polysomnography synchronization and calibration (subject 19). Figure S6 . Example of actigraphy-polysomnography synchronization and calibration (subject 33). Figure S7 . Example of actigraphy-polysomnography synchronization and calibration (subject 41).
